These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 19557156

  • 1. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.
    Croft NP, Shannon-Lowe C, Bell AI, Horst D, Kremmer E, Ressing ME, Wiertz EJ, Middeldorp JM, Rowe M, Rickinson AB, Hislop AD.
    PLoS Pathog; 2009 Jun; 5(6):e1000490. PubMed ID: 19557156
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection.
    Ressing ME, Keating SE, van Leeuwen D, Koppers-Lalic D, Pappworth IY, Wiertz EJ, Rowe M.
    J Immunol; 2005 Jun 01; 174(11):6829-38. PubMed ID: 15905524
    [Abstract] [Full Text] [Related]

  • 11. The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.
    Keating S, Prince S, Jones M, Rowe M.
    J Virol; 2002 Aug 01; 76(16):8179-88. PubMed ID: 12134023
    [Abstract] [Full Text] [Related]

  • 12. EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP.
    Horst D, Favaloro V, Vilardi F, van Leeuwen HC, Garstka MA, Hislop AD, Rabu C, Kremmer E, Rickinson AB, High S, Dobberstein B, Ressing ME, Wiertz EJ.
    J Immunol; 2011 Mar 15; 186(6):3594-605. PubMed ID: 21296983
    [Abstract] [Full Text] [Related]

  • 13. An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP.
    Bell MJ, Abbott RJ, Croft NP, Hislop AD, Burrows SR.
    J Virol; 2009 Mar 15; 83(6):2783-8. PubMed ID: 19129449
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
    Almohammed R, Osborn K, Ramasubramanyan S, Perez-Fernandez IBN, Godfrey A, Mancini EJ, Sinclair AJ.
    J Gen Virol; 2018 Jun 15; 99(6):805-817. PubMed ID: 29580369
    [Abstract] [Full Text] [Related]

  • 15. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 15; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 16. Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation.
    Smith C, Wakisaka N, Crough T, Peet J, Yoshizaki T, Beagley L, Khanna R.
    Blood; 2009 Jun 11; 113(24):6148-52. PubMed ID: 19372256
    [Abstract] [Full Text] [Related]

  • 17. Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.
    Adhikary D, Behrends U, Boerschmann H, Pfünder A, Burdach S, Moosmann A, Witter K, Bornkamm GW, Mautner J.
    PLoS One; 2007 Jul 04; 2(7):e583. PubMed ID: 17611619
    [Abstract] [Full Text] [Related]

  • 18. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates.
    Hislop AD, Ressing ME, van Leeuwen D, Pudney VA, Horst D, Koppers-Lalic D, Croft NP, Neefjes JJ, Rickinson AB, Wiertz EJ.
    J Exp Med; 2007 Aug 06; 204(8):1863-73. PubMed ID: 17620360
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells.
    Subklewe M, Paludan C, Tsang ML, Mahnke K, Steinman RM, Münz C.
    J Exp Med; 2001 Feb 05; 193(3):405-11. PubMed ID: 11157061
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.